BioVie Inc.
BIVI
$0.8408
$0.04766.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -71.30% | 15.97% | 38.76% | 3.97% | 21.56% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -74.74% | -42.42% | -30.08% | -23.13% | -18.78% |
| Total Other Non-Cash Items | 21.53% | -66.30% | 42.56% | 291.30% | -56.51% |
| Change in Net Operating Assets | -3,040.65% | 91.65% | -191.05% | -55.42% | 192.48% |
| Cash from Operations | -139.83% | 10.66% | 31.53% | 0.99% | 51.47% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -- | -- | -- | -- | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -34.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | 622.27% | -- | -100.00% | 148.93% | 289.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,482.69% | 90.36% | -115.65% | 224.57% | 928.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 214.70% | 41.28% | -164.27% | 1,124.66% | -156.33% |